Cummings, J., Ward, T. H., Greystoke, A., Ranson, M., & Dive, C. (2008). Biomarker method validation in anticancer drug development. British journal of pharmacology, 153(4), 646-656. https://doi.org/10.1038/sj.bjp.0707441
Chicago Style (17th ed.) CitationCummings, J., T H. Ward, A. Greystoke, M. Ranson, and C. Dive. "Biomarker Method Validation in Anticancer Drug Development." British Journal of Pharmacology 153, no. 4 (2008): 646-656. https://doi.org/10.1038/sj.bjp.0707441.
MLA (9th ed.) CitationCummings, J., et al. "Biomarker Method Validation in Anticancer Drug Development." British Journal of Pharmacology, vol. 153, no. 4, 2008, pp. 646-656, https://doi.org/10.1038/sj.bjp.0707441.
Warning: These citations may not always be 100% accurate.